Sade Biotech pioneers the accessibility of medical cannabis treatment for Alzheimer’s and Dementia patients
In January 2022, the Ministry of Health in Israel approved the use of medical cannabis to treat Dementia and Alzheimer’s in the adult population. Sade Biotech, the company behind ASAYA™ big-data platform, in cooperation with the National Pain Center, assist Alzheimer’s and dementia patients in the process of obtaining approval and then continuous monitoring of […]
Sadé Biotech And Its ASAYA™ Software Can now be Marketed in Europe
Excited to share with you that our ASAYA system was successfully registered with the Belgian Federal Agency for Medicines and Health Products and it is now CE marked. In addition, Sade Biotech and its ASAYA platform achieved the certification of several ISO Standards, including: ISO27001:2013, ISO27799:2016, and ISO 13485:2016. Our choice to walk the unbeaten […]
Sade Biotech Enters Exciting Collaboration with Leading Israeli Rehabilitation Center
At Sade, we’re always looking for new ways to collect, analyze, and harness collective wisdom on everything medical cannabis (MC), in order to provide the scores of people around the world living with chronic pain and debilitating conditions with the relief they so desperately deserve. Upon doing our due diligence, we came to understand that […]